Health Tech of the Week: Optimization of Treatment in the AI Era – How Pharmdiver Technologies Help Avoid Pharmacological Errors

In the first March entry of the „Health Tech of the Week” series, we return to the topic of pharmacology. Ensuring the safety of pharmacotherapy is one of the key challenges of modern medicine, requiring advanced analytical technologies and decision-support systems. Innovative solutions developed by Pharmdiver address these challenges by offering a comprehensive approach to therapy individualization and monitoring the risk of adverse drug reactions.

A fundamental issue in pharmacotherapy is the lack of sufficient treatment personalization that considers a patient’s unique characteristics, such as physiology, dietary habits, supplementation, and comorbidities. Pharmdiver’s modern technologies enable a holistic approach to pharmacotherapy safety by identifying drug interactions not only with other medications but also with food and dietary supplements. Pharmacokinetic and pharmacodynamic interaction analysis allows for the assessment of drug metabolism and therapy effectiveness.

– Our approach focuses on the patient as an individual with unique characteristics, including physiology, dietary habits, supplementation needs, and lifestyle. We do not treat the patient as an in vitro model, where only a single interaction is analyzed in isolation. In reality, the impact of pharmacotherapy is multidimensional, and our technology enables a comprehensive assessment of potential risks and optimization of therapy tailored to the specific individual – said Marta Jasiewicz, CEO of Pharmdiver.

This individualized approach to the patient is a fundamental pillar of the brand, guiding the development of innovative solutions. Pharmdiver has created several different products that address the most common pharmacological issues encountered by patients.

Analysis of drug interactions with supplements and food

Smart Pharma Finder+ is based on reliable scientific evidence, including meta-analyses, clinical studies, and systematic literature reviews. Interactions are classified according to their mechanisms and effects, with priority given to potentially dangerous interactions. Ambiguous cases are categorized as „other” to avoid overinterpretation.

A key element of this approach is the evaluation of drug-food interactions, considering both entire product groups and individual nutrients that may affect drug bioavailability. This allows doctors and pharmacists to plan patient therapy more comprehensively, minimizing the risk of adverse treatment effects.

On the other hand, AI-based products such as Smart Pharma Optimizer and Smart Pharma Finder+ utilize advanced algorithms combining hybrid artificial intelligence technologies, including natural language processing models (LLM) and classical machine learning (ML) methods. A crucial component of pharmacotherapeutic analysis is a graph database that identifies complex relationships between drugs and potential therapeutic risks.

Personalized treatment and physician support

Therapy individualization is one of the main challenges of modern medicine. Pharmdiver’s tools enable risk assessment for adverse drug reactions based on factors such as patient age, comorbidities, lifestyle, and pharmacotherapy regimen. Additionally, these systems support physicians in selecting safe medications and analyzing supplement ingredients, allowing for informed therapeutic decisions.

Errors in pharmacotherapy, resulting from incorrect prescriptions, cumulative adverse effects, or improper drug use, can lead to severe health consequences. Pharmdiver’s tools help reduce these risks by integrating pharmacotherapy safety data and monitoring the benefit-risk ratio of treatment.

Another important aspect is the verification of oral drug forms for decomposition feasibility. This analysis is invaluable for patients with dysphagia or those requiring drug administration via feeding tubes, ensuring therapy safety.

Innovative pharmacotherapy management

It is also worth mentioning the latest development, Smart Pharma Optimizer. This groundbreaking tool allows for the automatic summation of adverse drug effects and the assessment of their mathematical probability. By factoring in risk-modifying variables, a more precise pharmacotherapeutic analysis can be conducted, taking into account both individual patient characteristics and the specifics of the prescribed therapy.

– One of the key future directions we aim to explore is drug-disease interaction analysis. We strive to develop a tool capable of identifying cases where a disease modifies the pharmacokinetics or pharmacodynamics of a drug. In some instances, treatment exacerbates symptoms of comorbid conditions or even triggers the manifestation of a previously latent disease. Analyzing such interactions can ultimately improve pharmacotherapy effectiveness and safety – said CEO of Pharmdiver.

The Health Tech of the Week team is convinced that the development of advanced analytical tools such as Smart Pharma Optimizer and Smart Pharma Finder+ represents a significant step toward enhancing pharmacotherapy safety. By leveraging artificial intelligence, data integration, and advanced analytical algorithms, effective therapy personalization and medical error minimization become achievable. Implementing these technologies into clinical practice can contribute to improved patient health outcomes and optimize therapeutic processes in modern medicine.

—

Stay tuned for more in the “Health Tech of the Week” series, where we’ll continue to uncover fascinating stories from the world of medical technologies that are changing the face of healthcare. If you’re working on an innovative project in the field of new technologies and medicine or want to recommend an interesting solution, contact us at: [email protected].